2003 Journal Article Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked seraMcGrath, J. J., Eyles, Darryl Walter, Mowry, Bryan, Yolken, R. and Buka, S. (2003). Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophrenia Research, 63 (1 - 2), 73-78. doi: 10.1016/S0920-9964(02)00435-8 |
2003 Journal Article Vitamin D receptor expression in the embryonic rat brainBurket, Rachel, McGrath, John and Eyles, Darryl (2003). Vitamin D receptor expression in the embryonic rat brain. Neuroscience Research Communications, 33 (1), 63-71. doi: 10.1002/nrc.10081 |
2003 Journal Article The neurodevelopmental hypothesis of schizophrenia: a review of recent developmentsMcGrath, J. J., Feron, F. P., Burne, T. H. J., Mackay-Sim, A. and Eyles, D. W. (2003). The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Annals of Medicine, 35 (2), 86-93. doi: 10.1080/07853890310010005 |
2003 Journal Article 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neuronsBrown, Jillanne, Bianco, John I., McGrath, John J. and Eyles, Darryl W. (2003). 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neuroscience Letters, 343 (2), 139-143. doi: 10.1016/S0304-3940(03)00303-3 |
2003 Journal Article Vitamin D3 and brain developmentEyles, D., Brown, J., Mackay-Sim, A., McGrath, J. and Feron, F. (2003). Vitamin D3 and brain development. Neuroscience, 118 (3), 641-653. doi: 10.1016/S0306-4522(03)00040-X |
2002 Conference Publication Low vitamin D disrupts pre-pulse inhibition in adult but not young rats: A new animal model of schizophreniaMackay-Sim, A., Brown, J., Feron, F., Eyles, D. and McGrath, J. (2002). Low vitamin D disrupts pre-pulse inhibition in adult but not young rats: A new animal model of schizophrenia. XIth Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, 24 February - 1 March, 2002. AMSTERDAM: ELSEVIER SCIENCE BV. doi: 10.1016/S0920-9964(01)00381-4 |
2002 Journal Article Vitamin D-3 regulates the low affinity neurotrophin receptor P75 in the developing rat brainEyles, DW, Burkert, R and McGrath, J (2002). Vitamin D-3 regulates the low affinity neurotrophin receptor P75 in the developing rat brain. Schizophrenia Research, 53 (3), 228-228. |
2002 Conference Publication Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked seraMcGrath, J., Eyles, D., Mowry, B., Yolken, R. and Buka, S. (2002). Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. XIth Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, 24 February 2002. Amsterdam, Netherlands: Elsevier. |
2002 Conference Publication Vitamin D depletion during development markedly alters gene expression in the adult rat brain: Gene array assessment of a novel risk factor for schizophreniaFeron, F., Mackay-Sim, A., Eyles, D., Brown, J. and McGrath, J. (2002). Vitamin D depletion during development markedly alters gene expression in the adult rat brain: Gene array assessment of a novel risk factor for schizophrenia. XIth Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, 24 February - 1 March 2002. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0920-9964(01)00381-4 |
2002 Conference Publication Low maternal vitamin D-3 disrupts foetal brain maturationEyles, D. W., Feron, F., Brown, J., Mackay-Sim, A. and McGrath, J. (2002). Low maternal vitamin D-3 disrupts foetal brain maturation. XIth Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, 24 February 2002. Amsterdam, Netherlands: Elsevier. |
2002 Conference Publication Disruption of pro-differentiating signals may underlie both loss of cerebral asymmetry and craniofacial features in schizophreniaMcGrath, J., Eyles, D., Feron, F., Mackay-Sim, A. and Lieberman, D. (2002). Disruption of pro-differentiating signals may underlie both loss of cerebral asymmetry and craniofacial features in schizophrenia. XIth Biennial Winter Workshop on Schizophrenia, Davos, Switzerland, February 24–March 1, 2002. Amsterdam: Elsevier. doi: 10.1016/S0920-9964(01)00381-4 |
2002 Journal Article Neuronal calcium-binding proteins and schizophreniaEyles, DW, McGrath, JJ and Reynolds, GP (2002). Neuronal calcium-binding proteins and schizophrenia. Schizophrenia Research, 57 (1), 27-34. doi: 10.1016/S0920-9964(01)00299-7 |
2001 Journal Article Vitamin D insufficiency in south-east QueenslandMcGrath, J.J., Kimlin, M.G., Saha, S., Eyles, D.W. and Parisi, A.V. (2001). Vitamin D insufficiency in south-east Queensland. Medical Journal of Australia, 174 (3), 150-151. doi: 10.5694/j.1326-5377.2001.tb143195.x |
2001 Conference Publication The impact of low prenatal vitamin D on brain development: using an animal model to examine the vitamin D hypothesis of schizophreniaMcGrath, J. J., Feron, F., Eyles, D. W., Brown, J. and Mackay-Sim, A . (2001). The impact of low prenatal vitamin D on brain development: using an animal model to examine the vitamin D hypothesis of schizophrenia. VIIIth International Congress on Schizophrenia Research, British Columbia, Canada, 28 April-2 May 2001. Amsterdam, Netherlands: Elsevier. |
2001 Journal Article Vitamin D: the neglected neurosteroid?McGrath, J., Feron, F., Eyles, D. and Mackay-Sim, A. (2001). Vitamin D: the neglected neurosteroid?. Trends In Neurosciences, 24 (10), 570-571. doi: 10.1016/S0166-2236(00)01949-4 |
2000 Journal Article Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesiaEyles, Darryl W., Pond, Susan M., Van Der Schyf, Cornelis J. and Halliday, Glenda M. (2000). Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesia. Life Sciences, 66 (14), 1345-1350. doi: 10.1016/S0024-3205(00)00442-2 |
1998 Journal Article Chirality of reduced haloperidol in humansEyles, D.W., McGrath, J.J., Stedman, T.J. and Pond, S.M. (1998). Chirality of reduced haloperidol in humans. European Neuropsychopharmacology, 8 (2), 127-129. doi: 10.1016/S0924-977X(97)00049-7 |
1997 Journal Article Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortemEyles, Darryl W., Avent, Kathryn M., Stedman, Terry J. and Pond, Susan M. (1997). Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem. Life Sciences, 60 (8), 529-534. doi: 10.1016/S0024-3205(96)00656-X |
1996 Journal Article Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboonAvent, Kathryn M., Usuki, Etsuko, Eyles, Darryl W., Keeve, Ronel, Van Der Schyf, Cornelis J., Castagnoli Jr., Neal and Pond, Susan M. (1996). Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon. Life Sciences, 59 (17), 1473-1482. doi: 10.1016/0024-3205(96)00475-4 |
1996 Journal Article Formation of pyridinium species of haloperidol in human liver and brainEyles, D. W., McGrath, J. J. and Pond, S. M. (1996). Formation of pyridinium species of haloperidol in human liver and brain. Psychopharmacology, 125 (3), 214-219. doi: 10.1007/BF02247331 |